Coronary

View the latest content related to this topic

News Daily News

Frailty Extra Risky in Young Patients With Acute MI

For people younger than 55 years, frailty’s consequences appear to be more severe and its drivers more apt to be cardiometabolic.

Caitlin E. Cox

December 04, 2025

Slides

See all

Presentation ESC 2025

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

Presenter: David Newby

September 03, 2025

Presentation ESC 2025

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

Presenter: Anders Jeppsson

September 01, 2025

Presentation ESC 2025

Randomized trial of evolocumab on saphenous vein graft patency following coronary artery bypass surgery: The NEWTON-CABG CardioLink-5 Trial

Presenter: Subodh Verma

September 01, 2025

Presentation ESC 2025

SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease

Presenter: Mårten Falkenberg

August 31, 2025

Presentation ESC 2025

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Presenter: Duk-Woo Park

August 31, 2025

News

See all

News Daily News

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

By Yael L. Maxwell

December 05, 2025

News Daily News

Frailty Extra Risky in Young Patients With Acute MI

By Caitlin E. Cox

December 04, 2025

News Daily News

Reversal of Childhood Overweight May Prevent Later CHD Risks

By Todd Neale

December 03, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

By Caitlin E. Cox

December 01, 2025

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

By Michael O'Riordan

November 26, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Coronary

Frailty Extra Risky in Young Patients With Acute MI

Slides

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

Randomized trial of evolocumab on saphenous vein graft patency following coronary artery bypass surgery: The NEWTON-CABG CardioLink-5 Trial

SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

News

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

Frailty Extra Risky in Young Patients With Acute MI

Reversal of Childhood Overweight May Prevent Later CHD Risks

TCTMD’s Top 10 Most Popular Stories for November 2025

Frail Patients Stand to Gain Most From Cardiac Rehab

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Coronary

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content